We analyzed the level of IFN-gamma, TNF-alpha, IL-6, IL-17A, IL-10 and IL-4 at inclusion before start of anti-TB treatment and anti-helminthic drugs in helminth positive patients (t = 0) and at the 2 months follow-up (t = 2mo). The gene discussed is IL6; the disease is tuberculosis.